Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people starting Wegovy notice their appetite drops noticeably within the first few weeks, but it rarely disappears completely. Hunger doesn't vanish; it quietens. Semaglutide works by activating GLP-1 receptors that signal fullness to the brain and slow the rate at which your stomach empties, so meals feel satisfying on less food. That said, some people (particularly in the early weeks or after a dose increase) still feel real hunger at certain points in the day, and that's worth understanding rather than ignoring. Wegovy is a prescription-only medicine that a clinician assesses you for before prescribing; what you experience on it is something to discuss with your prescriber throughout treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's one of the questions our prescribers hear most frequently: "I thought this was supposed to stop me being hungry." The honest answer is that semaglutide reshapes appetite rather than eliminating it. In the STEP 1 trial published in the New England Journal of Medicine, participants on 2.4mg semaglutide lost an average of around 15% of body weight over 68 weeks, a result driven significantly by reduced calorie intake because food simply felt less appealing and meals felt more filling. But the mechanism is gradual. At 0.25mg or 0.5mg, which are the early titration doses, the effect on appetite is mild. The doses are that low because your digestive system needs time to adjust; nausea is common if you go too fast. So if you're in the first month or two and still feel genuinely hungry, that's pharmacologically expected, you haven't reached the doses where the fullness signal becomes consistent.
The 4pm dip is a classic example. Lunch sat better than it ever used to; you ate less and felt fine. Then mid-afternoon arrives and appetite surfaces. This tends to reduce as titration progresses, but in the meantime, a protein-rich mid-afternoon snack is a practical response, not a failure.
Not all hunger on Wegovy is the same thing. There's the ordinary appetite that persists at lower doses and fades with time. There's end-of-week hunger, which many people notice on day four or five after their injection as semaglutide levels begin to taper before the next dose, this is common enough that people specifically search for why Wegovy hunger peaks late in the week. And then there's hunger that signals you're not eating enough overall. Wegovy can suppress appetite so effectively at higher doses that some people under-eat without realising it, particularly protein, which matters for muscle preservation during weight loss.
The NHS guidance on weight-management injections is clear that treatment works alongside a reduced-calorie diet and increased physical activity, not instead of eating. Dropping calories far below maintenance in the hope of faster results is counterproductive; it increases fatigue, makes the common GI side effects feel worse, and doesn't lead to better long-term outcomes. If you're regularly feeling ravenous despite being on a higher dose, that's worth raising with your prescriber rather than assuming it's normal. Persistent, significant hunger mid-treatment is a reason to review the plan, not push through quietly.
Semaglutide slows gastric emptying, which means food sits in your stomach longer. This is the mechanism behind the fullness signal, but it also means fatty or very rich meals can cause nausea and discomfort because they stay around even longer. Smaller, more frequent meals tend to work better than two large ones. Protein at every meal (eggs, fish, chicken, legumes, Greek yoghurt) helps maintain muscle mass and produces a sustained fullness that complements the drug's own effect. Fibre from vegetables, fruit and wholegrains slows digestion further and feeds gut bacteria involved in appetite regulation.
Hydration matters more than people expect. Thirst and hunger share enough neurological overlap that mild dehydration regularly reads as hunger, drink water consistently through the day, not just when you feel thirsty. Some people find they stop feeling thirsty as reliably on Wegovy as they do hungry, so building a consistent fluid habit is worth it. For more detail on practical meal choices while on treatment, our guide to eating well on Wegovy covers this in full.
Timing matters too. If you inject on a Monday, some people find the day-four or day-five window (often a Friday) is the hardest for appetite. Planning ahead for that window (a good lunch, a protein-rich snack available) is less stressful than being caught off-guard on a Friday afternoon when the usual meal prep hasn't happened. A bit like the old trick of not going food shopping when hungry.
If you're consistently hungry despite being several months into treatment and on your maintenance dose, a few possibilities are worth exploring with your prescriber. Emotional eating (eating in response to stress, boredom or habit rather than physical hunger) is less well addressed by semaglutide than straightforward appetite, and some people find it helpful to recognise the difference. Our overview of Wegovy and emotional eating looks at this in more detail.
It's also worth knowing that persistent hunger on Wegovy sometimes reflects that the current dose isn't yet the right one for you, or that a different medicine might suit your biology better. Semaglutide and tirzepatide work on related but distinct receptor pathways, and some people respond better to one than the other, the prescriber's job is to keep that under review. The broader picture of hunger on semaglutide involves both Wegovy and Ozempic users asking the same question; the pharmacology is the same regardless of the brand.
If you'd like to explore whether Wegovy is the right treatment for you, or whether your current experience is something a prescriber should look at, check your eligibility with our clinical team, a GPhC-registered prescriber reads every consultation the same day it's submitted.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.